These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32296816)
21. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia. Lodise TP; Kwa A; Cosler L; Gupta R; Smith RP Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of the combination and quinolone therapy in community acquired pneumonia]. Kılıç Soylar Ö; Kılınç O; Ellidokuz H Tuberk Toraks; 2015 Sep; 63(3):165-9. PubMed ID: 26523897 [TBL] [Abstract][Full Text] [Related]
23. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial. Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Choi SH; Cesar A; Snow TAC; Saleem N; Arulkumaran N; Singer M Clin Infect Dis; 2023 Feb; 76(4):683-691. PubMed ID: 35903011 [TBL] [Abstract][Full Text] [Related]
26. Association of fluoroquinolones or cephalosporin plus macrolide with Patel P; Deshpande A; Yu PC; Imrey PB; Lindenauer PK; Zilberberg MD; Haessler S; Rothberg MB Infect Control Hosp Epidemiol; 2023 Jan; 44(1):47-54. PubMed ID: 35440348 [TBL] [Abstract][Full Text] [Related]
27. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Maimon N; Nopmaneejumruslers C; Marras TK Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053 [TBL] [Abstract][Full Text] [Related]
36. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349 [TBL] [Abstract][Full Text] [Related]
37. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis. Eljaaly K; Alshehri S; Aljabri A; Abraham I; Al Mohajer M; Kalil AC; Nix DE BMC Infect Dis; 2017 Jun; 17(1):385. PubMed ID: 28576117 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia]. Karaboğa B; Çilli A Tuberk Toraks; 2015 Jun; 63(2):94-101. PubMed ID: 26167966 [TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis. Salkind AR; Cuddy PG; Foxworth JW Ann Pharmacother; 2002 Dec; 36(12):1938-43. PubMed ID: 12452758 [TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Mykietiuk A; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F Clin Infect Dis; 2005 Mar; 40(6):794-9. PubMed ID: 15736010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]